Detection of mismatched human leukocyte antigens by adaptive immune cells is considered
as the main cause of transplant rejection, leading to either T-cell mediated rejection or …

Abstract The XVI-th Banff Meeting for Allograft Pathology was held at Banff, Alberta, Canada,
from 19th to 23rd September 2022, as a joint meeting with the Canadian Society of …

Rejection remains the main cause of premature graft loss after kidney transplantation,
despite the use of potent immunosuppression. This highlights the need to better understand …

With recent advances and commercial implementation of minimally invasive biomarkers in
kidney transplantation, new strategies for the surveillance of allograft health are emerging …

Abstract The XVIth Banff Meeting for Allograft Pathology was held in Banff, Alberta, Canada,
from September 19 to 23, 2022, as a joint meeting with the Canadian Society of …

Rationale & Objective Prior studies have demonstrated the diagnostic potential of urinary
chemokines CXC motif ligand 9 (CXCL9) and CXCL10 for kidney transplant rejection …

Background No validated system currently exists to realistically characterize the chronic
pathology of kidney transplants that represents the dynamic disease process and spectrum …

Background Donor-specific HLA antibody (DSA) is present in many kidney transplant
patients whose biopsies are classified as no rejection (NR). We explored whether in some …

Interpretation of kidney graft biopsies using the Banff classification is still heterogeneous. In
this study, extreme gradient boosting classifiers learned from two large training datasets (n …

Background. Microarray transcript analysis of human renal transplantation biopsies has
successfully identified the many patterns of graft rejection. To evaluate an alternative, this …